Back to News
Market Impact: 0.34

Here's Why Newmont Corporation (NEM) Fell More Than Broader Market

Corporate EarningsAnalyst EstimatesCompany FundamentalsMarket Technicals & FlowsCommodities & Raw Materials
Here's Why Newmont Corporation (NEM) Fell More Than Broader Market

Newmont fell 7.96% to $99.71, sharply underperforming the S&P 500's 2.65% decline, while shares are down 4.55% over the past month. The company is expected to report Q/EPS of $2.25 (+57.34% y/y) on revenue of $6.19B (+16.38% y/y), with full-year estimates at $9.91 EPS and $27.25B revenue. Despite a 7.53% increase in consensus EPS estimates over the past 30 days, Newmont remains a Zacks Rank #3 (Hold) and trades at a 10.94x forward P/E versus 9.45x for its industry.

Analysis

NEM’s drawdown looks less like a single-name deterioration and more like a de-risking of the gold-beta complex ahead of a crowded catalyst window. The key second-order issue is that miners with embedded operating leverage can underperform even when the underlying commodity is stable if investors start fading margin durability into a stronger USD, higher real-rate regime, or a post-event volatility crush after earnings. The stock’s premium multiple versus its peer set implies the market is already paying for execution, so any miss on costs, grades, or forward guidance would hit harder than the headline EPS print suggests.

The broader setup is also telling for relative value. If gold equities are being repriced lower while the industry ranking remains weak, capital is likely rotating toward better-quality Basic Materials names with cleaner end-demand visibility, which can create persistent underperformance for miners that rely on commodity price rather than volume growth. That dynamic tends to show up over weeks, not days, and is often amplified by systematic funds that screen on estimate revision momentum; a slowdown in upward revisions would remove the main support under the stock.

The contrarian case is that the recent selloff may already be discounting a high bar into earnings, making the risk/reward asymmetric for a tactical rebound if management merely confirms margin expansion and capital returns. But the bigger tell will be guidance around operating costs and reserve replacement: if those numbers worsen, the market may start treating the name as a cyclical with low conviction growth rather than a defensive commodity hedge. In that scenario, any relief rally should be sold rather than chased.